Temporal changes in the pathologic assessment of prostate cancer.

Abstract excerpt

Thirty years have witnessed dramatic changes in the manner in which we diagnose and manage prostate cancer. With prostate-specific antigen screening, there was a shift towards smaller, clinically localized tumors. Tumors are often multifocal and display phenotypic and molecular heterogeneity. Pathologic evaluation of tissue obtained by needle biopsy remains the gold standard for the diagnosis and risk assessment...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biopsy, Needle
• Share to Neoplasm Grading
• Share to Phenotype